Hear In Private Practice

by Michael Piskosz & Bill Schiffmiller Don’t worry, this isn’t another article that will barrage you with tinnitus statistics, facts, and figures. We see them non-stop and there are plenty of places to find them. Let’s be honest—these figures are nothing more than technical talking points that have very little influence on the real problem. These statistics don’t move the

by Michael Piskosz & Bill Schiffmiller An audiologist and a hearing aid user walk into a bar. They sit down, order a drink, and begin to chat about all things noise, sound, and hearing. The conversation quickly shifts to auditory healthcare, a topic both are intimately familiar with but from vastly different perspectives. Michael, the audiologist and a seasoned professional,

Audioscan recently introduced a unique over-the-counter / direct-to-consumer (OTC/DTC) device verification test suite for their Verifit2 system. Dr. John Pumford, Au.D., Director of Audiology, Education, and Clinical Research, answers key questions about this innovative tool and offers his expert perspective on the future of hearing care. What is the Audioscan OTC/ DTC test suite for Verifit2? Great question! The Audioscan

In the evolving landscape of healthcare, patient engagement has emerged as a pivotal element in delivering effective care, especially within specialized fields like audiology.  Audiologists face unique challenges, such as dealing with high no-show rates for first-time patients and the critical task of encouraging hearing aid adoption among those who need them. Additionally, many patients, when referred to audiologists for

Any business with more than two employees is likely to have a written set of policies and procedures. You know  – that binder hidden under a stack of papers on your desk where these policies and procedures reside, often collecting dust.  Eventually there is a moment – an occasion when your business gets into a jam, an employee has a

Long promoted as a test used in the hearing aid selection and fitting process, the Quick Speech in Noise (QuickSIN) might be about to enjoy a rebirth!  However, since surveys of clinical best practices have suggest less than 30% of audiologists conduct any type of speech in noise testing, it might be more apt to call it a birth. In late

With 2023 coming to a close, one year of OTC under our belts, and managed care continuing to gain traction in many parts of the country, it’s a good time to look ahead to 2024 and examine how the market for hearing devices and professional services will continue to evolve.  One positive development in 2023 that should continue to advance

This article explores the new Audible Contrast Threshold Test (ACT™) through a series of 10 questions answered by Ashley Hughes, Au.D., Clinical Applications Specialist at Interacoustics. Discover what ACT™ is and learn how to seamlessly integrate it into your clinical practice.  1. Could you provide a brief explanation of the Audible Contrast Threshold Test (ACT™)? Hughes: ACT™ is a nonlinguistic test, meaning

Many believe a clinically valid audiometric test must occur in a sound booth. This rationale is based on the assumption that only a sound booth can eliminate background noise and possible distractions that may lead to inaccurate test results. However, recent advances in audiometric technology are enabling a shift to testing outside of the booth. This shift is being widely

Hearing loss can affect anyone. The 2021 World Report on Hearing, published by the World Health Organization (WHO), found that there are over 1.5 billion people that live with some level of hearing loss. Even more concerning is that this figure is predicted to grow to an estimated 2.5 billion by 2050. This forecast is particularly alarming because most people